Nordic Luveris Study

• Status: Completed
• Trial end date: 2004-11-01
• Target enrollment: 0
• Participant gender: Female

Summary

To study whether addition of human LH hormone (Luveris) during the final days of stimulation with recombinant FSH (Gonal-f) for controlled ovarian stimulation will be of benefit for patients undergoing in vitro fertilisation.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Rigshospitalet, Denmark
• Collaborators: Helse Fonna; Herlev Hospital; Holbaek Sygehus; Hvidovre University Hospital; Karolinska University Hospital; Odense University Hospital; Regionshospitalet Viborg, Skive; Turku Hospital
• Treatments: Follicle Stimulating Hormone; Hormones

Criteria

Inclusion Criteria:

• Age below 40

• Infertility treatable by IVF or ICSI

• Regular cycles

Exclusion Criteria:

• NA